KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

EverQuote (EVER) Research & Development (2017 - 2025)

EverQuote's Research & Development history spans 8 years, with the latest figure at $8.3 million for Q4 2025.

  • For Q4 2025, Research & Development rose 8.68% year-over-year to $8.3 million; the TTM value through Dec 2025 reached $31.5 million, up 6.6%, while the annual FY2025 figure was $31.5 million, 6.6% up from the prior year.
  • Research & Development for Q4 2025 was $8.3 million at EverQuote, up from $7.9 million in the prior quarter.
  • Across five years, Research & Development topped out at $9.3 million in Q3 2021 and bottomed at $5.9 million in Q4 2023.
  • The 5-year median for Research & Development is $7.9 million (2022), against an average of $7.8 million.
  • The largest annual shift saw Research & Development decreased 20.11% in 2023 before it increased 28.53% in 2024.
  • A 5-year view of Research & Development shows it stood at $8.8 million in 2021, then fell by 15.9% to $7.4 million in 2022, then dropped by 20.11% to $5.9 million in 2023, then rose by 28.53% to $7.6 million in 2024, then grew by 8.68% to $8.3 million in 2025.
  • Per Business Quant, the three most recent readings for EVER's Research & Development are $8.3 million (Q4 2025), $7.9 million (Q3 2025), and $7.8 million (Q2 2025).